RIFCO 4000MG/500MG INJECTION
By Rifco
Rx
1 Injection in a Vial

Composition
Piperacillin(4000mg) + Tazobactum(500mg)

Manufacturer - Adley Formulations
Adley Formulation, SCO- 42, Sector 12, Panchkula-134112, Haryana, India

Expires on or after
July, 2026

liver
RIFCO 4000MG/500MG INJECTION is considered safe for use in patients with liver disease. The available data indicates that adjusting the dose of RIFCO 4000MG/500MG INJECTION may not be necessary for these patients. It is important to consult your doctor regarding the use of this injection to ensure proper guidance.

kidney
RIFCO 4000MG/500MG INJECTION requires caution in kidney disease patients. Adjusting the dosage may be necessary. Consult your doctor before use.

alcohol
When taking RIFCO 4000MG/500MG INJECTION, it is safe to consume alcohol as no harmful side effects have been reported.

driving
When using RIFCO 4000MG/500MG INJECTION, it is uncertain if driving ability is affected. Avoid driving if experiencing symptoms that impact concentration and reaction time.

pregnancy
RIFCO 4000MG/500MG INJECTION is generally safe to use during pregnancy based on animal studies with minimal adverse effects. Limited human studies are available.

breastfeeding
RIFCO 4000MG/500MG INJECTION is considered safe for use during breastfeeding based on human studies. The drug does not pass into breastmilk in a significant amount, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹504
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 18-Nov-2024